Premium
Dose‐Adjusted EPOCH ‐R and Mid‐Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement
Author(s) -
Chihara Dai,
Fowler Nathan H.,
Oki Yasuhiro,
Fanale Michelle A.,
Fayad Luis E.,
Westin Jason R.,
Hagemeister Fredrick B.
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14267
Subject(s) - methotrexate , lymphoma , medicine , antimetabolite , cancer research , oncology